ici 204,219 has been researched along with Infarction, Middle Cerebral Artery in 1 studies
zafirlukast: a leukotriene D4 receptor antagonist
Infarction, Middle Cerebral Artery: NECROSIS occurring in the MIDDLE CEREBRAL ARTERY distribution system which brings blood to the entire lateral aspects of each CEREBRAL HEMISPHERE. Clinical signs include impaired cognition; APHASIA; AGRAPHIA; weak and numbness in the face and arms, contralaterally or bilaterally depending on the infarction.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zeng, C | 1 |
| Wang, D | 1 |
| Chen, C | 1 |
| Chen, L | 1 |
| Chen, B | 1 |
| Li, L | 1 |
| Chen, M | 1 |
| Xing, H | 1 |
1 other study available for ici 204,219 and Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
Zafirlukast protects blood-brain barrier integrity from ischemic brain injury.
Topics: Animals; Blood-Brain Barrier; Brain Infarction; Cell Membrane Permeability; Disease Models, Animal; | 2020 |